OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease. OMass’ suite of proprietary technologies enables protein targets to be interrogated in a folded native-like state thereby preserving any associated non-covalent i...
OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease. OMass’ suite of proprietary technologies enables protein targets to be interrogated in a folded native-like state thereby preserving any associated non-covalent interactions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.